Skip to main content
Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
5.87
+0.41 (7.51%)
At close: Apr 23, 2025, 4:00 PM
5.82
-0.05 (-0.85%)
Pre-market: Apr 24, 2025, 4:04 AM EDT

Dogwood Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Dogwood Therapeutics stock has a target of 10, which predicts an increase of 70.36% from the current stock price of 5.87.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $10 $10 $10 $10
Change +70.36% +70.36% +70.36% +70.36%

Analyst Ratings

According to 1 stock analyst, the rating for Dogwood Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Apr '25
Strong Buy 1
Buy 0
Hold 0
Sell 0
Strong Sell 0
Total 1

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Sean Lee
HC Wainwright & Co.
 HC Wainwright & Co.
Strong Buy
Upgrades
$10
 Strong Buy Upgrades $10 +70.36% Apr 23, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 34.31M
Revenue Next Year
n/a
EPS This Year
-7.32
from -12.52
EPS Next Year
-4.51
from -7.32
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
 ---18.81M34.31M
Revenue Growth
 ----82.41%---
EPS
 -52.50-48.00-27.66-7.05-12.52-7.32-4.51-3.16
EPS Growth
 --------
Forward PE
 --------
No. Analysts
 -----555
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202520262027
High -4.25 -3.01 -2.45
Avg -7.32 -4.51 -3.16
Low -10.09 -5.86 -3.78

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.